What is Juvenile Myoclonic Epilepsy? Juvenile myoclonic epilepsy (JME) is an epileptic condition that develops in children and adolescents, invariably between the ages of 8 and 26 with most of the ...

This page lists all known medications that could potentially lead to 'Myoclonic epilepsy' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

What Is Juvenile Myoclonic Epilepsy (JME)? Also known as Janz syndrome, JME is a common generalised epilepsy disorder that typically begins in adolescence or early adulthood. It is characterised by ...

A 25-year follow-up study reveals that 68% of patients with juvenile myoclonic epilepsy (JME) became seizure-free, with nearly 30% no longer needing antiepileptic drug (AED) treatment. A 25-year ...

Background A 20-year-old woman presented to a specialist epilepsy center with a 3-year history of drug-resistant epileptic seizures, progressive myoclonus, ataxia, and cognitive decline.

Using Neuropixels probes, the scientists mapped the sequential approach by which interictal epileptiform discharges occur in ...

Gaucher disease, the inherited deficiency of lysosomal glucocerebrosidase, presents with a wide spectrum of manifestations. Although Gaucher disease has been divided into three clinical types, ...

A new study shows that wearable sensor technology can be used to reliably assess the occurrence of myoclonic jerks in patients with epilepsy also in the home environment. A new study by the University ...

Fast, reliable and automatic assessment of the severity of myoclonic jerks from video footage is now possible, thanks to an algorithm using deep convolutional neural network architecture and ...

A 20-year-old woman presented to a specialist epilepsy center with seizures, myoclonus, ataxia, and impaired executive functions. She was born to unrelated parents, had febrile seizures in infancy, ...

Background. A 20-year-old woman presented to a specialist epilepsy center with a 3-year history of drug-resistant epileptic seizures, progressive myoclonus, ataxia, and cognitive decline.